Investigations into the latency and incidence of mammary adenocarcinomas in Wnt1-transgenic mice determined that roughly 80% of mice had developed tumors by 7 months of age (19, 43), similar to our findings (Fig. 2A). This evidence concerns the gene WNT1 and breast adenocarcinoma.